Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Avantor ( (AVTR) ) is now available.
Avantor, Inc. has appointed Dame Louise Makin as an independent director to its Board, effective November 4, 2024, filling a vacant position. Known for her transformative leadership at BTG plc, where she spearheaded its growth from a $150 million company to its acquisition for $4.2 billion by Boston Scientific, Dame Louise brings extensive experience in the healthcare sector. Her role will include the standard compensation package for non-employee directors, emphasizing her strategic value to Avantor’s future endeavors.
See more data about AVTR stock on TipRanks’ Stock Analysis page.
